
Medtronic (MDT) Stock Forecast & Price Target
Medtronic (MDT) Analyst Ratings
Bulls say
Medtronic is a global leader in medical technology, with a diverse portfolio of products and a strong presence in both mature and emerging markets. The company's recent product launches and pipeline developments show potential for continued revenue growth and margin improvement. While there are some risks to consider, such as market competition and potential regulatory challenges, the overall outlook for Medtronic is positive.
Bears say
Medtronic is a large medical device company that manufactures and sells therapeutic devices for various chronic diseases. Despite its wide product portfolio and global presence, the company's recent earnings and guidance appear to be conservative and new product launches may not have enough impact to counter any potential market slowdowns. Additionally, clinical study results for the Intibia System and Medicare coverage for the Symplicity Spyral RDN System have not met expectations, which could hinder future revenue growth. Based on these factors, the analyst believes the company's stock is currently overvalued.
This aggregate rating is based on analysts' research of Medtronic and is not a guaranteed prediction by Public.com or investment advice.
Medtronic (MDT) Analyst Forecast & Price Prediction
Start investing in Medtronic (MDT)
Order type
Buy in
Order amount
Est. shares
0 shares